drugset / Trial / NCT02005991
A Study To Examine The Distribution Of PF-05212377 In The Brain Of Healthy Volunteer Subjects Using Positron Emission Tomography And A Radioactive Tracer Following Oral Administration Of One Dose Of PF-05212377
Non-randomizedParallel-groupOpen-labelBasic science
Summary
This study will see how PF-05212377, an experimental drug to treat symptoms from Alzheimer's Disease, distributes in the brain after one dose of PF-05212377 is administered orally to healthy volunteer subjects. The study will also evaluate the safety and tolerability of PF-05212377 in these subjects and will measure the level of PF-05212377 in the blood.
Timeline
- Start
- 2013-11
- Primary completion
- 2014-01
- Completion
- 2014-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-05212377 | Small molecule | 10 mg | Oral |
| Subject | PF-05212377 | Small molecule | 20 mg | Oral |
| Subject | PF-05212377 | Small molecule | 70 mg | Oral |
Indications
No indication recorded.